placeholder image

O. C. Danciu All authors

About

Publications While At HealthPartners

selected publications

Journal Article
  • Phase I dose-escalation study of procaspase-activating compound-1 in combination with temozolomide in patients with recurrent high-grade astrocytomas. 
  • Phase I study of procaspase-activating compound-1 (PAC-1) in the treatment of advanced malignancies. 
  • Phase I study of IGF-methotrexate conjugate in the treatment of advanced tumors expressing IGF-1R. 
  • Phase I study of aurora A kinase inhibitor alisertib (MLN8237) in combination with selective VEGFR inhibitor pazopanib for therapy of advanced solid tumors. 

    • Contact

    full name

  • O. C. Danciu

    • Quick Info

    Publications

    Collaboration